FOAMCOAT Drug Patent Profile
✉ Email this page to a colleague
When do Foamcoat patents expire, and when can generic versions of Foamcoat launch?
Foamcoat is a drug marketed by Guardian Drug and is included in one NDA.
The generic ingredient in FOAMCOAT is aluminum hydroxide; magnesium trisilicate. There are one hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aluminum hydroxide; magnesium trisilicate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FOAMCOAT?
- What are the global sales for FOAMCOAT?
- What is Average Wholesale Price for FOAMCOAT?
Summary for FOAMCOAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Patent Applications: | 75 |
| DailyMed Link: | FOAMCOAT at DailyMed |
US Patents and Regulatory Information for FOAMCOAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guardian Drug | FOAMCOAT | aluminum hydroxide; magnesium trisilicate | TABLET, CHEWABLE;ORAL | 071793-001 | Sep 4, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
